Signal Transducer and Activator of Transcription 6 (STAT6) is a pivotal transcription factor activated downstream of the interleukin-4 (IL-4) and interleukin-13 (IL-13) signaling pathways. It governs the expression of key genes involved in type 2 immune responses, including Th2 cell differentiation, IgE class switching, and M2 macrophage polarization. Dysregulated STAT6 activity has been implicated in a range of diseases, from asthma and atopic dermatitis to fibrosis and immune-evasive tumors.
With the clinical advancement of STAT6-targeting drugs like Kymera’s KT-621 and Recludix’s REX-8756, the demand for precise STAT6 binding profiling is rising—supporting target validation, mechanism studies, and therapeutic development.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
